Literature DB >> 10348231

Epidemic and endemic seroprevalence of antibodies to Cryptosporidium and Giardia in residents of three communities with different drinking water supplies.

J Isaac-Renton1, J Blatherwick, W R Bowie, M Fyfe, M Khan, A Li, A King, M McLean, L Medd, W Moorehead, C S Ong, W Robertson.   

Abstract

This study was carried out to compare cryptosporidiosis and giardiasis seroprevalence rates in residents of three communities. Community (Com 1) uses drinking water from deep wells, community 2 (Com 2) uses surface water from a protected watershed, and community 3 (Com 3) uses surface water frequently containing Cryptosporidium oocysts and Giardia cysts. Unfiltered drinking water from each community was collected at the tap and tested for Cryptosporidium oocysts and Giardia cysts during the 12 months in which sera were collected for testing. No oocysts or cysts were detected in the water from the Com 1 deep wells; oocysts and cysts were detected intermittently in the drinking water from the other two communities. A waterborne outbreak of cryptosporidiosis occurred in a municipality adjacent to Com 3 six months into this 12-month study. Sera from residents of each of the communities were collected proportionately by month and by population size. Coded sera were tested for IgG to Cryptosporidium using a previously developed Western blotting method. The presence or absence of bands at 15-17 kD and/or 27 kD was recorded for the 1,944 sera tested. Definite bands at 15-17 kD and/or 27 kD were detected in 981 (50.5%) of the sera. A total of 33.2% of sera from Com 1 (community using deep wells) were positive using the same criteria compared with 53.5% (Com 2) and 52.5% (Com 3) of sera from the two communities using surface drinking water. Both bands (15-17 kD plus 27 kD) were detected in 582 sera (29.9%) from the three communities: 14.1% of sera from Com 1 compared with 32.7% from Com 2 and 31.5% from Com 3. These findings are consistent with a lower risk of exposure to Cryptosporidium from drinking water obtained from deep well sources. However, analysis of results by calendar quarter showed a significant (P < 0.001) increase in the number of Com 3 positive sera (compared with Com 1) following the waterborne outbreak. Without this outbreak-related observation, a significant overall difference in seropositivity would not have been seen. We also observed that in sera from the community affected by the outbreak, the presence on immunoblots of both Cryptosporidium bands appeared to be the best indicator of recent infection. Seroprevalence rates using an ELISA to detect IgG to Giardia were estimated using the same sera. Overall 30.3% (590 of 1,944) of sera were positive by the ELISA. A total of 19.1% of sera from Com 1, 34.7% from Com 2 and 16.0% from Com 3 were seropositive. Rates for both Com 3 and Com 1 did not change significantly over time. In Com 2, rates decreased significantly (P < 0.001) during the last half of the study period (third and fourth calendar quarters). The reasons for the decrease in seroprevalence in Com 2 sera are presently not known. These studies show intriguing associations between seroprevalence, outbreak-related laboratory serologic data, and patterns of parasite contamination of drinking water. Further studies are required to validate the serologic approach to risk assessment of waterborne parasitic infections at a community level.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10348231     DOI: 10.4269/ajtmh.1999.60.578

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  14 in total

Review 1.  Cryptosporidiosis: environmental, therapeutic, and preventive challenges.

Authors:  S Collinet-Adler; H D Ward
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-06-04       Impact factor: 3.267

2.  Multiplex assay detection of immunoglobulin G antibodies that recognize Giardia intestinalis and Cryptosporidium parvum antigens.

Authors:  Jeffrey W Priest; Delynn M Moss; Govinda S Visvesvara; Cara C Jones; Anna Li; Judith L Isaac-Renton
Journal:  Clin Vaccine Immunol       Date:  2010-09-28

3.  Enzyme immunoassay detection of antigen-specific immunoglobulin g antibodies in longitudinal serum samples from patients with cryptosporidiosis.

Authors:  J W Priest; A Li; M Khan; M J Arrowood; P J Lammie; C S Ong; J M Roberts; J Isaac-Renton
Journal:  Clin Diagn Lab Immunol       Date:  2001-03

4.  High anti-Cryptosporidium parvum IgG seroprevalence in HIV-infected adults in Limpopo, South Africa.

Authors:  Luther A Bartelt; Jesus Emmanuel Sevilleja; Leah J Barrett; Cirle A Warren; Richard L Guerrant; Pascal O Bessong; Rebecca Dillingham; Amidou Samie
Journal:  Am J Trop Med Hyg       Date:  2013-07-08       Impact factor: 2.345

5.  Microarray analysis of the human antibody response to synthetic Cryptosporidium glycopeptides.

Authors:  Jamie Heimburg-Molinaro; Jeffrey W Priest; David Live; Geert-Jan Boons; Xuezheng Song; Richard D Cummings; Jan R Mead
Journal:  Int J Parasitol       Date:  2013-07-12       Impact factor: 3.981

6.  Longitudinal analysis of cryptosporidium species-specific immunoglobulin G antibody responses in Peruvian children.

Authors:  Jeffrey W Priest; Caryn Bern; Lihua Xiao; Jacquelin M Roberts; James P Kwon; Andres G Lescano; William Checkley; Lilia Cabrera; Delynn M Moss; Michael J Arrowood; Charles R Sterling; Robert H Gilman; Patrick J Lammie
Journal:  Clin Vaccine Immunol       Date:  2006-01

Review 7.  Treatment of giardiasis.

Authors:  T B Gardner; D R Hill
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

8.  Human parasitic protozoa in drinking water sources in rural Zimbabwe and their link to HIV infection.

Authors:  Sekesai Mtapuri-Zinyowera; Vurayai Ruhanya; Nicholas Midzi; Chipo Berejena; Nyasha Chin'ombe; Pasipanodya Nziramasanga; George Nyandoro; Takafira Mduluza
Journal:  Germs       Date:  2014-12-01

9.  Forest fragmentation and risk of giardiasis in New York State.

Authors:  Michael G Walsh
Journal:  Ecohealth       Date:  2013-10-19       Impact factor: 3.184

10.  Giardia and Cryptosporidium antibody prevalence and correlates of exposure among Alaska residents, 2007-2008.

Authors:  E Mosites; K Miernyk; J W Priest; D Bruden; D Hurlburt; A Parkinson; J Klejka; T Hennessy; M G Bruce
Journal:  Epidemiol Infect       Date:  2018-04-10       Impact factor: 4.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.